Preterm Birth Slightly Higher for Offspring of Young Male Patients With Cancer

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 5, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Feb. 5, 2025 -- The prevalence of preterm birth is slightly higher among liveborn offspring of male adolescents and young adults with cancer (AYAs; aged 15 to 39 years), according to a study published online Jan. 3 in the Journal of the National Cancer Institute.

Caitlin C. Murphy, Ph.D., M.P.H., from UTHealth Houston School of Public Health, and colleagues examined childbirth and perinatal outcomes among male AYAs diagnosed with cancer between Jan. 1, 1995, and Dec. 31, 2015, and identified using the Texas Cancer Registry.

A total of 42,896 male AYAs were identified, among whom germ cell cancers were the most common (20.0 percent). The researchers identified 9,686 live births to 6,833 male AYAs after diagnosis. At 10 years after diagnosis, the cumulative incidence of live birth was 18.0 percent; the 10-year cumulative incidence differed by cancer type and was highest and lowest for thyroid and gastrointestinal cancers, respectively (27.6 and 9.6 percent, respectively). Compared with age- and race/ethnicity-matched men without cancer, liveborn offspring of the male AYAs with cancer had higher prevalence rates of preterm birth (8.9 versus 8.0 percent) and low birth weight (6.0 versus 5.3 percent). No difference was seen in the prevalence of birth defects.

"Our study represents one of the first population-based assessments of childbirth and adverse perinatal outcomes among male AYAs in the U.S. and underscores the importance of continued efforts to provide comprehensive reproductive health counseling for AYAs," the authors write.

Two authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-02-06 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords